Is pharmacological treatment in the near future for PWS? with Dr. Gerald Maguire

Stutter Stories

Dr. Gerald Maguire is the world's frontrunner in pharmacological treatment research for stuttering. His personal connection with stuttering, academic background, professional experience and international links with top scientists have positioned him as the leading expert on medication's future role in the treatment of stuttering.

Dr. Maguire is a professor and Founding Chair of Psychiatry for the American University of Health Sciences School of Medicine in California. He is the principal investigator for CenExel CIT, Global Medical Director for iStutter, and Chair of Research and Development for the World Stuttering Network.

Dr. Maguire's disclosures include:

• Research Grants related to stuttering: Noema, Emalex.

• Other CNS research grants: Bioexcel, Neurocrine, Jazz, Sunovion, Karuna, Cerevel, Intracellular, Otsuka, Axsome

• Consultant/Advisor: Karuna, Sage/Biogen, Noema, Emalex

• Speakers’ Bureau: Alkermes, Janssen, Otsuka, Axsome

• No medication is FDA approved for stuttering

If you would like to learn more about the Orpheus Study and how to participate, click here:

https://www.orpheusstudy.com/WSN